SUPPORTing FDA’s fight against opioids abuse

Legislation President Donald Trump is expected to sign soon gives FDA powers that are intended to blunt the opioid abuse epidemic and incentivize development of non-addictive pain treatments.

The new authorities will give FDA tools it can use to slow the growth of opioid addiction stemming from careless prescribing, create scientific and medical opportunities for reducing patient exposure to opioids, and force drug manufacturers for the first time to develop data on the effects of long-term, chronic exposure to opioids. It may lead to restrictions on long-term use of certain opioids...